Professor Paul R. Martin is a faculty member at the University of Sydney within the Faculty of Medicine and Health and the Clinical Ophthalmology and Eye Health department. He received his PhD in Physiology from the University of Sydney in 1986 and completed postdoctoral work in Germany. His research focuses on visual neuroscience , particularly the structure and function of the visual system, retinal circuits, and the processing of color, form, and motion signals through evolutionary pathways. Key Research Themes: Neurosciences, Mental Health Keywords: Nervous System, Ophthalmology, Vision His work employs immunohistochemistry , microscopy , and single-cell recording to study retinal and brain pathways. He has active collaborations with institutions in the United States (University of Washington, Vanderbilt) and Hungary (University of Pécs). Grant funding includes projects on retinal mapping and neural pathways related to vision.
Javier Márquez Ruiz is a Professor at the Universidad Pablo de Olavide within the Department of Physiology, Anatomy and Cell Biology. His work focuses on translational neuroscience with emphasis on transcranial electrical stimulation , cerebellar plasticity , and neurodegenerative disorders . He leads the tNeuro Translational Neuroscience Group and collaborates with the Neuroscience Laboratory. PhD in Neuroscience (2008) from the University of Seville His research explores electrophysiological mechanisms underlying brain stimulation techniques using in vivo animal models , particularly awake mice and behaving rabbits. Key areas include excitation-inhibition balance , Purkinje cell dynamics , and translational applications for conditions like Alzheimer's and autism. Recent publications examine gamma-tACS and tDCS effects across cortical and cerebellar regions. His work integrates computational modeling with experimental neurophysiology to understand how non-invasive stimulation modulates sensory processing and motor learning. Though no formal awards are listed, his publications demonstrate sustained contributions to neural plasticity and neurostimulation research . He participates in doctoral programs related to neuronal plasticity and cerebral cortex oscillations .
Professor Marina Kennerson is a leading academic at the University of Sydney , affiliated with the Faculty of Medicine and Health and the School of Medical Sciences . She serves as Director of the Northcott Neuroscience Laboratory (ANZAC Research Institute), Principal Hospital Scientist at Concord Hospital's Molecular Medicine Laboratory, and Deputy Director (Research) for the Sydney Local Health District Institute of Precision Medicine and Bioinformatics. Her work focuses on Neurogenetics , particularly identifying causative genes for Inherited Peripheral Neuropathies (IPN), with over 25 years of experience in the field. Research Interests Gene discovery for IPN using genetic linkage and next-generation sequencing Functional genomics via iPSC-derived motor neurons and C. elegans models Transition of genomic technologies to clinical neurogenetic testing Leadership in global consortia like the Peripheral Nerve Society and Asian Oceanic Inherited Neuropathy Consortium Scientific Contributions Her research program integrates multiomics approaches with AI tools to analyze genomic data. She has identified 10 causative IPN genes and two structural variation mutations (DHMN1 and CMTX3), advancing pre-clinical modeling and therapeutic development. Her lab's work has established Concord Hospital as a reference center for IPN testing in Australia. Collaborations International partnerships include collaborations with: University of Malaya (Malaysia) – Dr. Azlina Ahmad-Annuar and Dr. Nortina Shahrizaila University of Miami (USA) – Professor Stephan Zuchner
Steven E. Hyman, M.D. is a Harvard University Distinguished Service Professor and Harald McPike Professor of Stem Cell and Regenerative Biology. He serves as Director of the Stanley Center for Psychiatric Research at the Broad Institute of Harvard and MIT, where he is also a Core Institute Member and Principal Faculty at the Harvard Stem Cell Institute. His work bridges neuroscience, psychiatry, and stem cell biology to address serious mental illness through translational research. Dr. Hyman received his B.A., summa cum laude, from Yale College, an M.A. from the University of Cambridge as a Mellon fellow studying history and philosophy of science, and an M.D., cum laude, from Harvard Medical School. His research spans multiple domains in neuroscience and psychiatry: Neuropsychiatric genetics and large-scale genomic studies of mental disorders Stem cell biology applications to psychiatric disorders Neurobiology of schizophrenia, bipolar disorder, and autism spectrum disorders Development of technology and biomarkers for psychiatric disorders Philosophical and ethical dimensions of psychiatric research and practice Analysis of his recent publications reveals a strong focus on the genetic architecture of psychiatric disorders, particularly schizophrenia, integrating large-scale genomic data with neurobiological mechanisms. His work emphasizes how genetic variants affect synaptic function and brain development, alongside philosophical considerations of psychiatric classification. Dr. Hyman has received numerous prestigious honors: Rhoda and Bernard Sarnat International Prize in Mental Health (2016) Fellow of the American Academy of Arts and Sciences Fellow of the American Association for the Advancement of Science Distinguished life fellow of the American Psychiatric Association Member of the National Academy of Medicine As Director of the Stanley Center, Hyman oversees substantial research funding for psychiatric genetics and neuroscience. The Center has launched major initiatives including the Stanley Global Neuropsychiatric Genetics Initiative and the Schizophrenia Spectrum Biomarkers Consortium. His leadership includes extensive mentorship through these large collaborative projects. Dr. Hyman directs the Stanley Center for Psychiatric Research, which engages in globally conducted studies of neuropsychiatric genetics, stem cell biology, and neurobiology. The Center includes the Schizophrenia Spectrum Biomarkers Consortium (SSBC), collecting comprehensive biological samples and phenotypic data from individuals with schizophrenia spectrum disorders. The Stanley Global initiative works with research groups worldwide to expand genetic sample collection across diverse populations.
Professor Bruno van Swinderen is a Professorial Research Fellow and Group Leader at the Queensland Brain Institute, University of Queensland, within the Faculty of Health, Medicine and Behavioural Sciences. With over two decades of neuroscience research experience, he leads a laboratory focused on understanding the neural mechanisms of consciousness using Drosophila (fruit fly) as a model organism. His work bridges molecular, electrophysiological, and behavioral approaches to uncover fundamental principles of brain function related to awareness and consciousness. Professor van Swinderen received his PhD in Evolutionary and Population Biology in 1998 from Washington University in St. Louis, Missouri. His graduate work focused on general anesthesia using Caenorhabditis elegans models, applying both quantitative genetics and molecular genetic approaches. He completed his postdoctoral training at The Neurosciences Institute (NSI) in San Diego, California (1999-2003), where he switched to Drosophila melanogaster to develop methods for studying perception. He established his independent laboratory at the Queensland Brain Institute in February 2008. His research centers on understanding consciousness through three brain states where awareness is lost: selective attention, sleep, and general anesthesia. His laboratory uses Drosophila as a genetic model system to investigate visual perception across different arousal states, with particular focus on how sleep regulates selective attention and predictive processing. The lab employs novel visual paradigms within a Drosophila molecular genetics context, examining how neural circuits process information when consciousness is altered or diminished. A key insight from his work is that fundamental mechanisms of consciousness are conserved across species, challenging assumptions about the uniqueness of human consciousness. Professor van Swinderen has proposed that we dream to first become conscious as babies and then to stay conscious as adults, an adaptive hypothesis linked to predictive processing theory. His recent publications reveal increasingly sophisticated methodologies including whole-brain electrophysiology, calcium imaging, and molecular analyses that have identified specific neural mechanisms underlying sleep homeostasis, anesthesia effects, and attention processes. A notable trend is the integration of computational approaches with traditional neuroscience techniques, allowing for nuanced analysis of complex brain activity patterns. His work demonstrates that flies exhibit surprisingly complex brain functions previously thought to be exclusive to higher organisms, with implications for understanding human consciousness and developing new approaches to anesthesia and sleep disorders. Professor van Swinderen maintains an active research program with numerous collaborations, as evidenced by his extensive publication record. His laboratory continues to push methodological boundaries while maintaining focus on core questions about what makes a brain conscious, contributing significantly to our understanding of brain states where awareness is lost.
Prof. Dr. Stephan Neuhauss leads the Molecular Life Sciences research group at the University of Zurich's Faculty of Science. His lab specializes in zebrafish models for studying retinal biology, visual system development, and heritable human diseases. The Neuhauss Lab has made significant contributions to understanding photoreceptor function, glutamate signaling, and ciliopathies through genetic and physiological approaches. Research Focus : Retinal phototransduction mechanisms Zebrafish models for medulloblastoma Glutamate homeostasis in CNS Evolution of vision-related gene families Scientific Trends : His 15 most recent publications (2016-2025) reveal a strong focus on zebrafish genetics, retinal disorders, and innovative biomedical technologies. Key subfields include photoreceptor biology, ciliary gene function, synaptic transmission mechanisms, and translational cancer research. Recognition : Best Presentation Awards (2025) SNF Förderprofessorship (2019) CandDoc Forschungskredit (2018) Academic Leadership : As Vice-Dean for Research and Planning (2017-), he has shaped Zurich's scientific landscape while mentoring numerous PhD and Master's students including Jingjing Zang, Irene Ojeda Naharros, and Ruxandra Bachmann-Gagescu.
Jose Rodriguez is an Associate Professor at the Department of Chemistry and Biochemistry, University of California, Los Angeles (UCLA), with a focus on Structural Biology , Computational Biology , and Biophysics . His research spans Nanoscience , Biochemistry , and Amyloid Research . His lab develops advanced methods in Electron Diffraction (MicroED) and X-ray Imaging to study: Prions & Amyloid Structures in neurodegenerative diseases Structural Dynamics under electron beam damage 3D Nanocrystallography for molecular lattices Viral Glycoproteins for therapeutic targeting Recent publications highlight his work on MicroED methodology (2025), radiolytic damage analysis (2025), and prion-like domain regulation (2025). His lab is based in Boyer Hall at UCLA. His graduate students include Becky, Jess, Lily, Niko, Nina, Eric, Nima, Aldo, Cameron, and Phoebe. No scientific awards are explicitly mentioned in the provided text.
Frank G. Whitby is a Research Professor in the Department of Biochemistry at the University of Utah, where his research centers on high-resolution structural biology and drug discovery. He earned a BS from the University of Denver, a PhD in Biochemistry from Rice University, and pursued postdoctoral training at both the University of Utah and the University of California. His laboratory uses X-ray crystallography to illuminate molecular mechanisms governing viral entry, proteasome function, porphyrin metabolism, and neurotransmission. Education University of Utah – Postdoctoral Fellowship University of California – Postdoctoral Fellowship Rice University – PhD University of Denver – BS Research Interests Whitby’s investigations integrate structural and biochemical approaches to dissect macromolecular machines that underpin human disease. Current foci include: Conformational dynamics of the 20S proteasome and its regulatory complexes Structural determinants of HIV and ebolavirus membrane fusion Mechanistic enzymology of porphyrin biosynthetic enzymes Neuroreceptor regulation and synaptic signaling Structure-guided optimization of small-molecule therapeutics for metabolic and infectious diseases Scientific Contributions & Trends Across more than 50 peer-reviewed publications, Whitby has provided landmark crystal structures for proteasome activators, viral glycoproteins, and metabolic enzymes. His recent work (2021–2024) emphasizes translational applications, revealing how subtle structural changes can be exploited to design potent inhibitors against galactokinase, HIV gp41, and malaria cytochrome c. A consistent theme is the integration of high-resolution structures with functional assays to accelerate therapeutic development. Awards & Recognition Although the supplied text does not enumerate specific awards, Whitby’s sustained funding and prolific publication record in high-impact journals ( Nature , Cell , PNAS , Journal of Biological Chemistry ) underscore his international recognition in structural biology and chemical biology communities. Collaborations & Teams Whitby is a core member of the University of Utah’s Structural Biology Facility and actively collaborates with medicinal chemists, virologists, and neuroscientists worldwide. His multi-disciplinary projects are supported by federal grants and industry partnerships aimed at translating structural insights into novel therapeutics.
KC Brennan is a Professor of Neurology and Adjunct Professor of Neurobiology at the University of Utah School of Medicine, where he directs research on migraine pathophysiology and headache disorders. His clinical expertise focuses on complex headache management, with research centered on cortical spreading depression (CSD) as the neural basis of migraine aura and its implications for traumatic brain injury, stroke, and epilepsy. Dr. Brennan's educational background includes: B.A. from Georgetown University M.D. from Columbia University College of Physicians and Surgeons His laboratory investigates brain excitability derangements using optical intrinsic signal imaging , two-photon microscopy , voltage-sensitive dye imaging , and electrophysiology . Key research themes include CSD initiation mechanisms in genetic migraine models, environmental triggers (e.g., high-altitude effects), and sensory processing abnormalities in headache disorders. His work bridges molecular neuroscience with clinical applications to develop targeted migraine therapies. Analysis of his recent publications (2023-2025) reveals three dominant trends: (1) Elucidating the migraine aura-headache link through genetic and environmental models, (2) Developing quantitative clinical tools like the Utah Photophobia Scale, and (3) Exploring therapeutic interventions (e.g., ketamine for neuronal recovery post-CSD). His research spans basic neurophysiology, translational models, and clinical epidemiology across diverse populations including older adults and hematological disorder patients. No specific scientific awards are documented in the provided information. While student mentorship details are unavailable, Dr. Brennan's active publications and laboratory operations indicate ongoing research funding. His work involves multidisciplinary collaborations across neurology, neurobiology, and headache medicine specialties. Dr. Brennan leads a neuroscience laboratory focused on CSD dynamics using advanced optical and electrophysiological techniques. His team investigates neuronal-glial interactions in migraine models, with particular emphasis on sensory hypersensitivity mechanisms and neurovascular coupling. Current projects include studying migraine in high-altitude environments and developing biomarkers for headache-related disability.
Jun Yang is a Professor at the Department of Ophthalmology and Visual Sciences and Adjunct Professor in Neurobiology at University of Utah Health. His research focuses on the genetics and cell biology of photoreceptors and hair cells, particularly in relation to Usher syndrome and retinal degeneration. Education: B.S. from Nankai University, Ph.D. from University of Massachusetts Amherst Yang's lab investigates molecular mechanisms of heritable retinal degeneration, including photoreceptor trafficking, calcium regulation, and the multi-protein Usher II complex. His work explores gene therapy approaches using AAV vectors to treat mouse models of retinal diseases. The 15 most recent publications highlight studies on CFAP418-lipid interactions, USH2 complex integrity, photoreceptor disc morphogenesis, TRPV1 channel regulation, and stereocilia development. These works span molecular genetics, protein biochemistry, and translational therapies for sensory cilia disorders. His research has been published in journals like JCI Insight , Human Molecular Genetics , and PLoS Genetics , with a focus on protein-protein interactions, ciliary rootlet structure, and membrane homeostasis. Collaborative projects include studies on cytomegalovirus-induced hearing loss and therapeutic interventions. Jun Yang's laboratory at University of Utah Health employs mouse genetics, molecular biology, and advanced microscopy to understand and develop treatments for retinal and auditory degeneration diseases.
Alexandra Catherine Byrne serves as Assistant Professor in the Department of Neurobiology within the T.H. Chan School of Medicine at UMass Chan Medical School. She holds additional appointments in the NeuroNexus Institute and the Morningside Graduate School of Biomedical Sciences, where she is affiliated with the Interdisciplinary Graduate Program, Neuroscience Graduate Program, and Postbaccalaureate Research Education Program (PREP). Her laboratory investigates fundamental mechanisms of nervous system repair with direct relevance to human neurological conditions. Her academic background includes: PhD in Molecular Genetics from the University of Toronto, Toronto, ON, Canada Postdoctoral training at Yale University, New Haven, CT, USA Dr. Byrne's research focuses on the genetically regulated loss of axon regenerative capacity during aging. Using C. elegans as a model system, her lab employs laser axotomy, functional genomics, and advanced imaging to identify conserved molecular pathways. Key investigations include the roles of TIR-1/SARM1 in axon degeneration, PARP in synapse reformation, and DLK/PTEN pathways in regeneration. Her work demonstrates that regenerative decline is an active biological process rather than passive deterioration, with implications for spinal cord injury and neurodegenerative diseases. Analysis of her publication record reveals consistent emphasis on molecular regulators of axon regeneration and degeneration across 2014-2025. The research bridges C. elegans genetics with mammalian relevance, particularly through conserved pathways like SARM1 and PARP. Recent work explores bacterial interactions in neuroprotection and functional recovery mechanisms, indicating expanding translational horizons. No scientific awards or fellowships are documented in the provided materials. Dr. Byrne actively mentors eight trainees including current PhD candidates Lauren O'Connor, Wenjia Huang, Eli Min, Brendan Philippon, Emily Goetz, and PREP scholar Noelia Genao, plus alumni Victoria Czech and Micah Belew. Her lab's publication output and active recruitment for research positions indicate successful grant funding, though specific awards aren't detailed in available information. The Byrne Lab operates within UMass Chan's Department of Neurobiology and NeuroNexus Institute, utilizing C. elegans for high-resolution in vivo studies. The collaborative environment includes shared resources for laser axotomy, behavioral assays, and molecular genetics. Current recruitment for lab manager and postdoctoral positions reflects expanding research scope into neurodegeneration and functional regeneration mechanisms.
Jennifer E. Cremins is an Associate Professor and Deans' Distinguished Scholar in Engineering and Medicine at the University of Pennsylvania, with primary appointments in the Department of Bioengineering and secondary appointment in Genetics. She leads the Cremins Laboratory, which works at the spatial biology-technology interface to investigate the structure-function relationship of connections across the scales of chromatin, synapses, and circuits in the developing and diseased mammalian brain. Dr. Cremins' research focuses on understanding how the genome's three-dimensional architecture influences neural development, function, and disease. Her lab has made foundational contributions to elucidating chromatin's higher-order folding patterns at kilobase-resolution during neural lineage commitment, maturation, activity stimulation, and in neurological disorders. The lab's work bridges chromatin folding, synaptic plasticity, and neurophysiology to elucidate how the genome's structure-function relationship influences synaptic defects in neurodevelopmental, neuropsychiatric, and neurodegenerative disorders. Analysis of Dr. Cremins' recent publications reveals a strong focus on the relationship between chromatin architecture and neurological disorders, particularly Alzheimer's disease, fragile X syndrome, and autism spectrum disorders. Her work increasingly integrates computational approaches with experimental techniques to study genome organization at single-cell resolution, with significant emphasis on the role of short tandem repeat expansions in neurodegenerative conditions. Dr. Cremins' laboratory has received significant recognition through numerous scientific awards and fellowships: Deans' Distinguished Scholar in Engineering and Medicine Funding from New York Stem Cell Foundation, Alfred P. Sloan Foundation Support from National Science Foundation, National Institutes of Health (NIMH, NINDS) Grants from Friedreich's Ataxia Research Alliance, Chan Zuckerberg Initiative Funding from Cure Huntington's Disease Initiative, NIH 4D Nucleome Common Fund As an educator and mentor, Dr. Cremins has developed the SEEDS (Summer Exploration in Epigenetics and Data Science) program, a four-year interdisciplinary training program for undergraduates. All 15 graduates of her SEEDs/SEEDs-BRIDGE programs remain in scientific careers, including PhD programs at MIT and UPenn, MD-PhD programs at Mayo, UCSF, and NYU, and MD programs at various institutions. She also develops structured active learning courses focused on statistics, probability, and coding for spatial epigenetics data analysis. The Cremins Laboratory maintains a vibrant research environment with multiple postdoctoral fellows, graduate students, and undergraduate researchers working at the intersection of chromatin biology, neuroscience, and computational genomics. The lab is particularly known for its work on the 4D nucleome and its relationship to neurological disorders, using cutting-edge techniques like Oligopaints imaging and developing computational tools like FISHnet for analyzing chromatin architecture.
Shane Crandall serves as Assistant Professor in the Department of Physiology and BioMolecular Science Gateway at Michigan State University, where he directs research in the Neuroscience Program. His laboratory operates from the Biomedical Physical Sciences Building (Room 2100) in East Lansing, Michigan. His academic training includes: B.A. in Neuroscience, Boston University (2005) Ph.D. in Neuroscience, University of Illinois Urbana-Champaign (2012) Postdoctoral Fellowship, Brown University (2012-2017) Dr. Crandall's research program investigates neural circuit mechanisms underlying sensory perception, with primary focus on dynamic neocortex-thalamus interactions. His laboratory examines how these circuits process signals essential for sensation, movement, and cognition, and how their dysfunction contributes to neurological disorders including epilepsy and Tuberous Sclerosis Complex (TSC). Key methodologies include: Electrophysiological and optical recording in awake behaving mice Multi-scale circuit analysis from single neurons to network dynamics Studies of corticothalamic and intracortical pathway modulation TSC-related circuit abnormality characterization Analysis of recent publications (2022-2024) reveals intensifying focus on layer 6 corticothalamic feedback circuits and motor-sensory integration. His team employs selective optical stimulation to dissect parallel pathways, demonstrating how specific interneuron subtypes (particularly somatostatin-expressing) mediate top-down modulation of somatosensory processing. This work establishes critical links between circuit dynamics and neurological disease mechanisms. Dr. Crandall actively mentors postdoctoral researchers, Ph.D. students, and undergraduates, with current recruitment ongoing for all levels. His laboratory maintains strong collaborative ties within MSU's Neuroscience Program and Department of Physiology. The research facility in Biomedical Physical Sciences Building integrates advanced electrophysiology with optical techniques for comprehensive neural circuit analysis in both in vitro and awake behaving preparations, supporting investigations into fundamental sensory processing mechanisms and disease models.
Kyle E Miller serves as an Associate Professor at Michigan State University with cross-program appointments in the Integrative Biology Faculty, Neuroscience Program, and Genetics & Genome Sciences Program. His laboratory operates from room 337 of the Natural Science Building, where he leads research on fundamental mechanisms of neuronal development. Dr. Miller's research program centers on elucidating the biophysical and molecular mechanisms underlying axon growth. His laboratory employs an integrative methodology combining time-lapse microscopy in living Drosophila embryos and cultured neurons, mathematical modeling of cytoskeletal dynamics, targeted gene disruption, and biophysical force measurements. This multidisciplinary approach specifically investigates organelle biogenesis, transport kinetics, and cytoskeletal element degradation during neurite outgrowth, with translational aims toward improving treatments for traumatic brain injury, spinal cord injury, stroke, and chronic neurodegenerative conditions. Analysis of his 15 most recent publications (2017-2025) reveals three dominant research trajectories: (1) evolutionary hypotheses connecting cytokinesis to neuronal development, (2) active fluid modeling of cytoskeletal mechanics in axonal elongation, and (3) molecular motor regulation of organelle transport (particularly mitochondria and lysosomes). These works consistently bridge neuroscience, cell biology, and biophysics through innovative combinations of in vivo imaging and computational approaches. No scientific awards are documented in the available materials. Dr. Miller maintains an active research laboratory conducting both basic and translational neuroscience investigations, though specific grant funding details and student mentorship records are not provided in the source documentation. The Miller Lab utilizes Drosophila embryonic models and primary neuronal cultures to dissect the mechanical and molecular drivers of axonal elongation, with particular emphasis on microtubule dynamics, molecular motor function, and the evolutionary origins of neuronal structures.
Franco Onofri is an Associate Professor in the Department of Experimental Medicine (DIMES) at the University of Genoa. His research focuses on molecular neuroscience and neurophysiology, particularly mechanisms of synaptic plasticity and neuronal development. Department: DIMES (Experimental Medicine) Email: franco.onofri@unige.it Phone: +39 010 353 7967 Research interests include: Neuroplasticity regulation through epigenetic mechanisms Role of synapsin proteins in neuronal development Calcium signaling in presynaptic function Neuroprotective effects of plant-derived compounds Neurodegenerative disorder pathophysiology Homeostatic synaptic plasticity Recent publication trends show emphasis on molecular regulation of neuronal networks, with specific focus on REST/NRSF transcription factors, synapsin proteins, and natural bioactive compounds for neuroprotection.
